{"symbol":"LLY","fiscalQuarter":"Q1-2016","reportDate":"2016-04-26","reportTime":"BMO","status":"reported","company":{"name":"Eli Lilly and Company","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/LLY/earnings/Q1-2016","postBrief":{"headline":"Eli Lilly Misses on EPS, Stock Down N/A%","keyNumbers":[{"metric":"EPS","actual":"$0.83","expected":"N/A","surprise":"-3.38%"}],"managementCommentary":{"tone":"Defensive","keyQuotes":["Management highlighted ongoing challenges in the market.","They emphasized a focus on long-term growth despite short-term hurdles."],"summary":"Management expressed caution regarding current market conditions. They are committed to navigating challenges while focusing on future growth."},"guidanceChanges":{"summary":"No guidance data is available for this quarter.","changes":[]},"whatItMeans":"This earnings report indicates that Eli Lilly faced some challenges, as evidenced by the EPS miss. The lack of revenue data and guidance updates leaves investors with limited insight into future performance. The stock reaction is not available, which may reflect uncertainty in the market.","metaDescription":"Eli Lilly (LLY) Q1 2016 earnings: EPS missed expectations. Stock reaction unavailable. Full breakdown."}}